Mmcap updates -- october 2008

Minnesota Multistate Contracting Alliance for Pharmacy
651-201-2420
www.mmcap.org
MMCAP NEWS

MMCAP News is issued monthly to provide members with the latest information on the MMCAP
program. The newsletter is sent to the MMCAP State Contacts, and they forward it to the member
facilities in their state.
NATIONAL MEMBER CONFERENCE
MMCAP 2014 National Member Conference
Planning for the 2014 NMC will begin shortly and we are currently forming the NMC Planning
Committee. If you are interested in serving on this committee please contact Daniel Callahan,
The conference facility RFP has been drafted and sent to the
Advisory Board for review; results of this solicitation will identify exact location and dates.
ADVISORY BOARD NEWS
Mid-Year Advisory Board Meeting
A mid-year meeting of the MMCAP Leadership Team and the Advisory Board is planned for
October 8 and 9. The meeting will be a strategic planning session to finalize MMCAP goals for the
next one or two years. Details of the meeting structure will be shared as they are developed.

MARKETING & COMMUNICATIONS
Website Training Presentation
For those interested in learning a bit more about the ins and outs of MMCAP.org, a training
presentation has been created and posted online. The goal of the website tutorial is to help
members navigate the MMCAP website and become aware of the value-added programs. The
Website Training Presentation may be viewed by anyone, without logging in to the MMCAP
website, www.MMCAP.org by selectingfrom the top banner then selecting the
icon labeled Website Training Presentation.
State Contact Binders
We are developing MMCAP binders for all of our State Contacts, as a quick reference guide to aid
in performing the duties of an MMCAP State Contact and to help you with transition of
responsibility and education for supervisors, legislators and member agencies. If you have ideas or
suggestions for reference materials you might find particularly helpful, please contact
Communications Coordinator Daniel Callahan at
Field Services: Senior Account Executives
The Senior Account Executives in the East, Southeast and Northwest have been active in the field
for a few weeks now and have met with many of the MMCAP State Contacts and wholesaler
representatives, and plan to schedule meetings with members in their territories. If you have
questions about the role of the MMCAP Senior Account Executives, contact Carolyn O’Donnell at

VACCINE PROGRAM
Research Grant Opportunity
Pfizer, a contracted MMCAP vendor, has released information regarding the ASPIRE Grants for
Adult Vaccine Research, a program Pfizer supports in efforts to advance “medical knowledge of
vaccines and vaccine-preventable diseases.” For more information, visit
NON-PHARMACEUTICAL PROGRAM
Medical Supply Vendor Webpages
We reached out to our contracted Medical Supply vendors – Medline, McKesson, Henry Schein,
PSS World Medical and Cardinal Health – to offer them the opportunity to create a MMCAP-
specific webpage to streamline the process of purchasing on contract. To date, the offer has been
accepted by at least one of our vendors and links will be or do already appear on the Medical
Supply pag
Any questions or comments can be directed to Jim Losinski, Medical Supply Program
Coordinator, at

MONTHLY MEMBER CALL PRESENTATION
Want in discussing your facilities approach to public health initiatives? Want to share a success story? We’re looking for volunteers to lead a short presentation/discussion during this month’s member call. If you’re interested and willing, please contact Communications Coordinator Daniel Callahan at
PHARMACEUTICAL PROGRAM
Generic Pharmaceutical and OTC Products RFP
The new generic pharmaceutical contracts will be in place on July 1, 2013. MMCAP is currently
working with contracted pharmaceutical vendors and wholesalers to ensure contracts are properly
loaded and contracted product is available for purchase on July 1.
To prepare for a smooth transition to the pharmaceuticals awarded in the RFP, MMCAP
recommends alerting all impacted staff of the July 1st conversion and preparing for
implementation processes.
Over the next several weeks MMCAP and the wholesalers will provide information on tools that
can be used to manage the new contracts, including reporting features, shelf labels and contact
information. Please log into the MMCAP website then click on Member News, MMCAP News,
Pharmaceutical Wholesaler Program for updated information.
eAudit Contract Extended
MMCAP’s contract with eAudit Solutions was extended to Jan. 31, 2014. An RFP for contract
price auditing services was released earlier this year, but MMCAP found it necessary to reissue the
RFP. The new RFP for contract price auditing services is due on May 15, 2013.
340B GPO Prohibition Deadline Extension
The Health Resources and Services Administration (HRSA) extended the deadline for
disproportionate share hospitals (DSH), children’s hospitals, and freestanding cancer hospitals to
make certain their drug replenishment practices comply with the GPO policy release to Aug. 7,
2013. MMCAP members that participate in the 340B program and are classified as DSH,
children’s hospitals, and freestanding cancer hospitals must work with their wholesalers to make
sure no accounts are attached to MMCAP contract pricing. According to HRSA, no additional
extensions will be granted beyond the August 7 date. For more information, please visit the HRSA
website: http://www.hrsa.gov/opa/faqs/
Mallinckrodt’s Methadone Allocation Lifted
Mallinckrodt has lifted its allocation on the following products:
NDC #
Product Description
Methadone Hydrochloride Tablets, USP (5 mg) Methadone Hydrochloride Tablets, USP (10 mg)
Pricing Changes
VendName
TRADE DESCRIPTION
PACKAGING Eff_Date
% Difference
Price increase 00087086644 D-VI-SOL 400 UNITS/ML DROP Price increase 67457011850 ASCORBIC ACID 500 MG/ML VIAL Price increase 00574722612 COMPRO 25 MG SUPPOSITORY Price increase 45802066033 CLINDAMYCIN PHOSPHATE 1% FOAM Price increase 45802066032 CLINDAMYCIN PHOSPHATE 1% FOAM Price increase 45802042237 DESONIDE 0.05% CREAM Price increase 45802042335 DESONIDE 0.05% OINTMENT Price increase 45802042337 DESONIDE 0.05% OINTMENT Price increase 45802096694 ERYTHROMYCIN 2% GEL Price increase 45802096696 ERYTHROMYCIN 2% GEL Price increase 45802012935 HALOBETASOL PROP 0.05% CREAM Price increase 45802012932 HALOBETASOL PROP 0.05% CREAM Price increase 45802013135 HALOBETASOL PROP 0.05% OINTMNT 15GM x 1 Price increase 45802013132 HALOBETASOL PROP 0.05% OINTMNT 50GM x 1 Price increase 45802093064 HYDROCORTISONE-IODOQUINOL CRM 28.4GM x 1 Price increase 45802098064 HYDROQUINONE 4% CREAM Price increase 45802053233 KETOCONAZOLE 2% FOAM Price increase 45802053232 KETOCONAZOLE 2% FOAM Price increase 45802071708 TERCONAZOLE 80 MG SUPPOSITORY Price increase 45802036235 TRETINOIN 0.01% GEL Price increase 45802036242 TRETINOIN 0.01% GEL Price increase 45802036335 TRETINOIN 0.025% GEL Price increase 45802036342 TRETINOIN 0.025% GEL Price increase 45802036102 TRETINOIN 0.05% CREAM Price increase 45802036142 TRETINOIN 0.05% CREAM Price increase 45802018302 TRETINOIN 0.1% CREAM Price increase 45802018342 TRETINOIN 0.1% CREAM QUALITEST PHARMACEUTICALS, INC Price increase 00603150858 PHENOBARBITAL 20 MG/5 ML ELIX QUALITEST PHARMACEUTICALS, INC Price increase 00603072854 CODITUSS DM SYRUP QUALITEST PHARMACEUTICALS, INC Price increase 00603116158 DICYCLOMINE 10 MG/5 ML SYRUP Price increase 51672130606 ALCLOMETASONE DIPRO 0.05% CRM Price increase 51672130603 ALCLOMETASONE DIPRO 0.05% CRM Price increase 51672401106 CLOMIPRAMINE 25 MG CAPSULE Price increase 51672401105 CLOMIPRAMINE 25 MG CAPSULE Price increase 51672401206 CLOMIPRAMINE 50 MG CAPSULE Price increase 51672401205 CLOMIPRAMINE 50 MG CAPSULE Price increase 51672401306 CLOMIPRAMINE 75 MG CAPSULE Price increase 51672401305 CLOMIPRAMINE 75 MG CAPSULE Price increase 51672128001 DESONIDE 0.05% CREAM Price increase 51672130200 TERCONAZOLE 0.8% CREAM Price increase 00093423201 BUMETANIDE 0.5 MG TABLET Price increase 00093423310 BUMETANIDE 1 MG TABLET Price increase 00093423301 BUMETANIDE 1 MG TABLET Price increase 00093423401 BUMETANIDE 2 MG TABLET Price increase 00472091202 METRONIDAZOLE 0.75% LOTION Price increase 00472173803 MICONAZOLE 3 200 MG VAG SUPP
Product News
Novolog Penfill
Eligible MMCAP Participating Facilities currently on the Committed Gold tier should see a price
decrease on the Novolog Penfill (NDC 00169-3303-12) effective April 1, 2015. Please check the
“Reduced Pricing Opportunities” section of the MMCAP website to view the specific discount
rates and tiers for the eligible MMCAP Participating Facilities. If you need assistance with
locating the “Reduced Pricing Opportunities” section of the MMCAP website, please contact
Daniel Callahan at
GSK Consumer Contract Available
A recent contract with GSK Consumer Healthcare has brought Biotene, Nicoderm, Nicorette,
Abreva and Sarna products on contract with MMCAP. Members can now purchase these products
at a discounted rate. Pricing information can be found in the MMCAP Catalog, accessible through
or wholesalers’ ordering systems.
Reckitt Benckiser Contract Now Available
MMCAP signed a contract with Reckitt Benckiser for its OTC products effective April 15, 2013.
Products such as Mucinex, Delsym, Lanacane, and Cepacol are now on contract and are available
through MMCAP’s wholesalers, AmerisourceBergen, Cardinal, and Morris & Dickson. Pricing
information can be found online in MMCAP’s Catalog or wholesalers’ ordering systems.

MMCAP’s Weekly Highlights Bulletin
On a weekly basis, MMCAP sends out a contract highlights bulletin. This bulletin provides
information related to products that are added to or removed from the MMCAP contract, undergo
NDC changes, or that increase or decrease in price. The bulletin is posted online in MMCAP’s
Catalog under Bulletins and is also sent to MMCAP State Contacts, the MMCAP Advisory Board,
and other individuals who have asked to receive it. The bulletin does not contain any pricing, but
indicates product changes including NDC, price increases and price decreases. If you would like to
receive the contracts highlights bulletin, contact mmcastate.mn.us.
MMCAP’s Prime Vendor Coordinator
Laura Muetzel, MMCAP’s Prime Vendor Coordinator, will be leaving MMCAP to pursue other
opportunities effective May 10, 2013. Laura has worked for MMCAP for over two years and has
worked to keep MMCAP’s wholesalers compliant and contributed to several large projects.
MMCAP will be hiring for this position as soon as possible. Questions or issues with
AmerisourceBergen, Cardinal, or Morris & Dickson should be sent to Sara Turnbow, at
until a new coordinator can be hired. Please join MMCAP in wishing
Laura good luck in her future endeavors!
MMCAP STAFF CONFERENCE ATTENDANCE
NASPO 2013 Marketing Meeting Summary
On behalf of MMCAP, Alan Dahlgren, Rose Svitak and Carolyn O’Donnell attended the 2013
How to Market to State Governments Meeting sponsored by the National Association of State
Procurement Officials (NASPO). This meeting was held April 14-16, 2013, in Indianapolis. The
marketing focus of this meeting included one-on-one sessions for vendors to meet with state
procurement directors, Regional Roundtable sessions, and presentations geared to help vendors
conduct business with state government. The MMCAP attendees spoke with procurement directors
from many states, with the NASPO officials, and with the MMCAP Indiana State Contact, Kathy
Harrington.
Spring Conference on Correctional Health Care
Dave Hoang attended the Spring Conference on Correctional Health Care, April 20-23, 2013, in
Denver, Colorado. MMCAP uses this opportunity to gain greater insight into the issues currently
facing our correctional members. Key presentations topics from recognized industry experts
included health care reform and its relation to corrections, and multimodal treatment strategies for
psychological disorders in incarcerated patient populations.

GENERAL INFORMATION
Florida Update
In late January 2013, Florida issued an Intent to Award the pharmaceutical contract to MMCAP.
Subsequent to the Intent to Award, one of the vendors that answered the Florida solicitation
protested the Intent to Award to MMCAP. The protest is expected to be resolved by late June.
Meanwhile, MMCAP still has the existing pharmaceutical contract with Florida.
MMCAP Email LISTSERVs
For more in depth information on MMCAP and related topics you’re invited to join the MMCAP
email LISTSERVs. To be included in the group sharing information on Pharmacy topics, contact
Dave Hoang atincluded in the group sharing information on
Procurement topics, contact Jennifer Faricy at

News Posted on MMCAP Website
Looking for back issues of the MMCAP News? The three most recent editions of the monthly
MMCAP News are posted on the website. To access the MMCAP News, log in to the website,
select “Member News” from the top banner, then “MMCAP News” from the
left side list, then “MMCAP Monthly Member News” from the list of choices.
Find MMCAP_Online
Check out MMCAP_Online on your favorite social media sites for news and updates.

Monthly Call-In Opportunity
MMCAP will be hosting an opportunity for members to discuss issues on May 15, 2013. The call
begins promptly at 11 a.m., CST. As a courtesy to all MMCAP members on the call, please put
your phone on mute to minimize background noise.
Check your emailed calendar invitation/appointment for the call-in number and access code. If you
are a new state contact or if you have any questions regarding the call, contact MMCAP at

If you have any questions, please contact MMCAP by phone at 651-201-2420, or email Thank you for choosing MMCAP!

Source: http://vendornet.state.wi.us/vendornet/wais/bulldocs/2477_45.PDF